Blood Thinner Lowers Clot Risk in Plastic Surgery Patients
In Highest-Risk Group, Enoxaparin Reduces Venous Thromboembolism Rate by 60 PercentArlington Heights, Ill. – For plastic surgery patients at high risk, treatment with the anticoagulant (blood-thinning) drug enoxaparin can reduce the risk of serious blood clot-related complications called venous thromboembolism (VTE), reports a study in the November issue of Plastic and Reconstructive Surgery® , the official medical journal of the American Society of Plastic Surgeons (ASPS). The results suggest that enoxaparin could